Clinical Trials Arena January 8, 2025
The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for sponsors and CROs to optimize budgets and resources. We explore the key trends to look out for in 2025.
2025 is set to be another significant year for clinical trials. According to GlobalData’s Clinical Trials database, as of January 2025, there are 3,213 trials planned to start this year – including 823 in Phase I and 1,102 in Phase II. As with 2024, oncology is expected to remain the top therapeutic area, accounting for 946 trials, followed by central nervous system with 686 trials, then cardiovascular some way behind with 258 trials.
The headwinds and tailwinds facing these trials include...
Today's Sponsors
Today's Sponsor